Biosketch / Results /



Contact Info


Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer
Singh, JC; Novik, Y; Stein, S; Volm, M; Meyers, M; Smith, J; Omene, C; Speyer, J; Schneider, R; Jhaveri, K; Formenti, S; Kyriakou, V; Joseph, B; Goldberg, JD; Li, X; Adams, S; Tiersten, A
2014-07-03; 1465-542x,Breast cancer research - id: 1059672, year: 2014

RAD001-carboplatin combination in triple-negative metastatic breast cancer (TNMBC): A phase II trial
Singh, J C; Stein, S; Volm, M; Smith, J A; Adams, S; Meyers, M; Speyer, J L; Novik, Y; Schneider, R; Formenti, S; Muggia, F; Jhaveri, K L; Goldberg, J D; Heese, S; Li, X; Davis, S; Tiersten, A
2013-07-25; 0732-183x,Journal of clinical oncology - id: 452012, year: 2013

Standardizing quality breast cancer care throughout all New York university facilities
Pavlick, A C; Schnabel, F R; Tiersten, A; Volm, M; Wu, J J; Boester, C; Carroll, W L
2013-07-01; 0732-183x,Journal of clinical oncology - id: 408932, year: 2012

Phase II trial of RAD001 plus carboplatin in patients with triple-negative metastatic breast cancer
Singh, J C; Stein, S; Volm, M; Smith, J A; Novik, Y; Speyer, J L; Meyers, M; Adams, S; Omene, C O; Muggia, F; Schneider, R; Formenti, S; Davis, S; Beardslee, B; Tiersten, A
2013-03-27; 0732-183x,Journal of clinical oncology - id: 249952, year: 2012

Efficacy of RAD001/carboplatin in triple-negative metastatic breast cancer: A phase II study
Singh, J C; Volm, M; Novik, Y; Speyer, J L; Adams, S; Omene, C O; Meyers, M I; Smith, J A; Schneider, R; Formenti, S; Goldberg, J D; Li, X; Davis, S; Beardslee, B; Tiersten, A
2013-06-25; 0732-183x,Journal of clinical oncology - id: 395172, year: 2012